Àü¸³¼±¾Ï Áø´Ü ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м® ¹× ¿¹Ãø(2024-2032³â)
Prostate Cancer Diagnostics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
»óǰÄÚµå : 1618189
¸®¼­Ä¡»ç : Global Market Insights Inc.
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 115 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 7,017,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,050 £Ü 8,753,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,350 £Ü 12,081,000
PDF & Excel (Enterprise User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Àü ¼¼°è Àü¸³¼±¾Ï Áø´Ü ½ÃÀåÀº 2023³â 45¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024-2032³â°£ ¿¬Æò±Õ 10.5%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå È®´ëÀÇ ¹è°æ¿¡´Â Àü¸³¼±¾Ï ¹ßº´·ü Áõ°¡, À§Çè ¿äÀο¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ±â¼ú ¹ßÀü, Çõ½ÅÀûÀÎ Áø´Ü ¹æ¹ý¿¡ ´ëÇÑ ¸·´ëÇÑ ÅõÀÚ°¡ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÇÕÀûÀÎ ¿äÀεéÀÌ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. Àü¸³¼±¾ÏÀÌ Æ¯È÷ ³ë³âÃþ¿¡¼­ ¸¹ÀÌ ¹ß»ýÇÔ¿¡ µû¶ó Àû½Ã¿¡ Á¤È®ÇÑ Áø´Ü µµ±¸¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °øÁߺ¸°Ç Ä·ÆäÀΰú ÀÎ½Ä °³¼± Ȱµ¿Àº ³²¼ºµéÀÌ Á¤±âÀûÀÎ °ËÁøÀ» ¹Þµµ·Ï µ¶·ÁÇÏ¸ç ½ÃÀå ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, Á¶±â ¹ß°ß°ú ¸ÂÃãÇü Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ °ü½ÉÀº ÷´Ü Áø´Ü ±â¼úÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. 2023³â Áø´Ü °Ë»ç ½ÃÀåÀº Áø´Ü °Ë»ç¿Í ¿µ»ó °Ë»ç·Î ±¸ºÐµÇ¸ç, Áø´Ü °Ë»ç´Â 2023³â 29¾ï ´Þ·¯ÀÇ ¸ÅÃâÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Âµ¥, ÀÌ´Â ÁÖ·Î Á¶±â ¹ß°ß¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â PSA(Àü¸³¼± ƯÀÌ Ç׿ø) °Ë»ç°¡ ƯÈ÷ Áß¿äÇѵ¥, PSA °Ë»ç´Â Ç÷¾× ³» ¾Ï °ü·Ã ´Ü¹éÁúÀÇ ¼öÄ¡¸¦ ÃøÁ¤ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÃøÁ¤Çϱ⠶§¹®¿¡ ƯÈ÷ Áß¿äÇÕ´Ï´Ù.

PSA °Ë»ç´Â ƯÈ÷ 50¼¼ ÀÌ»ó ³²¼ºÀÇ Á¤±â °Ç°­°ËÁø¿¡ ÀϹÝÀûÀ¸·Î »ç¿ëµÇ¸ç, °Ë»ç ¹Î°¨µµ°¡ Çâ»óµÊ¿¡ µû¶ó ¾Ï ¹ß°ß¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¾Ï À¯Çüº°·Î´Â Àü¸³¼±¾ÏÀÇ 95% ÀÌ»óÀ» Â÷ÁöÇÏ´Â Àü¸³¼± ¼±¾ÏÀÌ 2023³â 41¾ï ´Þ·¯·Î °¡Àå ³ôÀº ¸ÅÃâÀ» ±â·ÏÇß½À´Ï´Ù. Àü¸³¼±ÀÇ ¼±¼¼Æ÷¸¦ ħ¹üÇÏ´Â ÀÌ À¯ÇüÀÇ ¾ÏÀº °¡Àå ³Î¸® ÆÛÁ® ÀÖ¾î Àü¹®ÀûÀÎ Áø´Ü µµ±¸ÀÇ Çʿ伺ÀÌ ´ëµÎµÇ°í ÀÖÀ¸¸ç, 2023³â 18¾ï ´Þ·¯ÀÇ ¸ÅÃâÀ» ±â·ÏÇÑ ºÏ¹Ì ½ÃÀåÀº 2032³â±îÁö ¿¬Æò±Õ 9.9%ÀÇ ³ôÀº ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº ³ôÀº ÀÎÁöµµ, ¼±ÁøÈ­µÈ ÀÇ·á ÀÎÇÁ¶ó, Á¤±âÀûÀÎ °ËÁø ÇÁ·Î±×·¥ÀÇ Á¶ÇÕ¿¡ ÀÇÇØ ÃËÁøµÉ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, FDA¿Í °°Àº ±ÔÁ¦ ±â°üÀº ¾×ü »ý°Ë ¹× À¯ÀüÀÚ °Ë»ç¸¦ Æ÷ÇÔÇÑ Çõ½ÅÀûÀÎ Áø´Ü ¼Ö·ç¼ÇÀÇ ½Å¼ÓÇÑ µµÀÔÀ» Áö¿øÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀåÀÇ ¼ºÀå ÀáÀç·ÂÀ» ´õ¿í ³ôÀ̰í ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2023³â
¿¹Ãø ¿¬µµ 2024-2032³â
½ÃÀÛ °¡°Ý 45¾ï ´Þ·¯
¿¹»ó °¡°Ý 111¾ï ´Þ·¯
CAGR 10.5%

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå »ê¾÷ ÀλçÀÌÆ®

Á¦4Àå °æÀï ±¸µµ

Á¦5Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : °Ë»ç À¯Çüº°, 2021-2032³â

Á¦6Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ¾Ï À¯Çüº°, 2021-2032³â

Á¦7Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2021-2032³â

Á¦8Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : Áö¿ªº°, 2021-2032³â

Á¦9Àå ±â¾÷ °³¿ä

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Prostate Cancer Diagnostics Market was valued at USD 4.5 billion in 2023 and is projected to grow at a CAGR of 10.5% from 2024 to 2032. This expansion is driven by the rising incidence of prostate cancer, increasing awareness about risk factors, technological advancements, and significant investments in innovative diagnostic methods. These combined factors are pushing the market forward. As prostate cancer becomes more prevalent, especially among aging populations, there is a growing need for timely and accurate diagnostic tools. Public health campaigns and awareness efforts encourage men to undergo regular screenings, further propelling market demand.

Additionally, the focus on early detection and personalized treatment options is boosting the adoption of advanced diagnostic technologies. The market is segmented by test type into diagnostic tests and imaging tests, with diagnostic tests leading the way. In 2023, diagnostic tests generated USD 2.9 billion in revenue, largely due to their critical role in early detection. The PSA (prostate-specific antigen) test is particularly crucial, as it measures the level of this cancer-related protein in the blood.

PSA testing is commonly used in routine health checks, particularly for men over 50, and with advancements in testing sensitivity, these diagnostics continue to play a vital role in cancer detection. In terms of cancer types, the prostatic adenocarcinoma, which accounts for over 95% of prostate cancer cases, generated the highest revenue at USD 4.1 billion in 2023. This type of cancer, affecting the gland cells of the prostate, is the most prevalent, driving the need for specialized diagnostic tools. The North America market, which accounted for USD 1.8 billion in revenue in 2023, is anticipated to grow significantly at a CAGR of 9.9% through 2032. This growth is fueled by a combination of high awareness levels, advanced healthcare infrastructure, and regular screening programs. Additionally, regulatory bodies such as the FDA support the rapid adoption of innovative diagnostic solutions, including liquid biopsy and genetic testing, further enhancing the market's growth potential.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$4.5 Billion
Forecast Value$11.1 Billion
CAGR10.5%

Table of Contents

Chapter 1 Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Industry Insights

Chapter 4 Competitive Landscape, 2023

Chapter 5 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

Chapter 6 Market Estimates and Forecast, By Cancer Type, 2021 - 2032 ($ Mn)

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

Chapter 9 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â